> top > docs > PMC:3359311 > spans > 117-1955 > annotations

PMC:3359311 / 117-1955 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T364 171-189 P01584 denotes Interleukin-1 beta
T365 191-196 P01584 denotes IL-1β
T366 263-268 P01584 denotes IL-1β
T367 354-359 P01584 denotes IL-1β
T368 452-457 P01584 denotes IL-1β
T369 640-645 P01584 denotes IL-1β
T370 894-899 P01584 denotes IL-1β
T371 1064-1069 P01584 denotes IL-1β
T372 1132-1137 P01584 denotes IL-1β
T373 1331-1336 P01584 denotes IL-1β
T374 1340-1344 P10145 denotes IL-8
T375 1495-1500 P01584 denotes IL-1β
T376 1585-1590 P01584 denotes IL-1β
T377 1725-1730 P01584 denotes IL-1β

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation Speculation
T49 590-597 Gene_expression denotes produce true
T50 629-639 Positive_regulation denotes stimulated
T40 171-189 Protein denotes Interleukin-1 beta
T41 191-196 Protein denotes IL-1β
T42 230-239 Localization denotes Secretion
T43 263-268 Protein denotes IL-1β
T44 269-277 Regulation denotes involves
T45 354-359 Protein denotes IL-1β
T46 443-451 Positive_regulation denotes mediated true
T47 452-457 Protein denotes IL-1β
T48 458-468 Gene_expression denotes production
T51 640-645 Protein denotes IL-1β
T52 868-876 Gene_expression denotes produced
T53 894-899 Protein denotes IL-1β
T54 944-948 Positive_regulation denotes upon
T55 1064-1069 Protein denotes IL-1β
T56 1070-1080 Gene_expression denotes production
T57 1086-1096 Positive_regulation denotes stimulated
T58 1132-1137 Protein denotes IL-1β
T59 1325-1330 Regulation denotes alter true
T60 1331-1336 Protein denotes IL-1β
T61 1345-1355 Gene_expression denotes production
T62 1356-1370 Positive_regulation denotes in response to
T63 1470-1477 Positive_regulation denotes induced
T64 1495-1500 Protein denotes IL-1β
T65 1547-1556 Positive_regulation denotes preserved
T66 1585-1590 Protein denotes IL-1β
T67 1591-1600 Localization denotes secretion
T68 1715-1724 Positive_regulation denotes increased
T69 1724-1730 Protein denotes IL-1β
T70 1731-1741 Gene_expression denotes production
T71 1760-1763 Positive_regulation denotes due true
R25 T41 T40 equivalentTo IL-1β,Interleukin-1 beta
R26 T42 T44 themeOf Secretion,involves
R27 T43 T42 themeOf IL-1β,Secretion
R28 T47 T48 themeOf IL-1β,production
R29 T48 T46 themeOf production,mediated
R30 T49 T50 themeOf produce,stimulated
R31 T51 T49 themeOf IL-1β,produce
R32 T52 T54 themeOf produced,upon
R33 T53 T52 themeOf IL-1β,produced
R34 T55 T56 themeOf IL-1β,production
R35 T56 T57 themeOf production,stimulated
R36 T60 T61 themeOf IL-1β,production
R37 T61 T62 themeOf production,in response to
R38 T62 T59 themeOf in response to,alter
R39 T64 T63 themeOf IL-1β,induced
R40 T66 T67 themeOf IL-1β,secretion
R41 T67 T65 themeOf secretion,preserved
R42 T68 T71 themeOf increased,due
R43 T69 T70 themeOf IL-1β,production
R44 T70 T68 themeOf production,increased

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T802 171-189 Protein denotes Interleukin-1 beta
T803 191-196 Protein denotes IL-1β
T804 220-228 Positive_regulation denotes mediator
T805 220-228 Positive_regulation denotes mediator
T806 263-268 Protein denotes IL-1β
T807 230-239 Localization denotes Secretion
T808 354-359 Protein denotes IL-1β
T809 640-645 Protein denotes IL-1β
T810 720-729 Protein denotes caspase-1
T811 590-597 Gene_expression denotes produce
T812 709-719 Positive_regulation denotes upregulate
T813 894-899 Protein denotes IL-1β
T814 925-934 Protein denotes caspase-1
T815 868-876 Gene_expression denotes produced
T816 913-924 Positive_regulation denotes upregulated
T817 883-890 Positive_regulation denotes amounts
T818 1039-1048 Protein denotes caspase-1
T819 1064-1069 Protein denotes IL-1β
T820 1049-1059 Positive_regulation denotes activation
T821 1070-1080 Gene_expression denotes production
T822 1049-1059 Positive_regulation denotes activation
T823 1132-1137 Protein denotes IL-1β
T824 1166-1171 Protein denotes NF-κB
T825 1138-1148 Gene_expression denotes production
T826 1153-1162 Positive_regulation denotes dependent
T827 1194-1202 Positive_regulation denotes enhanced
T828 1256-1260 Protein denotes CFTR
T829 1331-1336 Protein denotes IL-1β
T830 1340-1344 Protein denotes IL-8
T831 1242-1252 Negative_regulation denotes inhibition
T832 1345-1355 Gene_expression denotes production
T833 1345-1355 Gene_expression denotes production
T834 1325-1330 Positive_regulation denotes alter
T835 1325-1330 Positive_regulation denotes alter
T836 1495-1500 Protein denotes IL-1β
T837 1585-1590 Protein denotes IL-1β
T838 1626-1660 Protein denotes CF pathogen Pseudomonas aeruginosa
T839 1591-1600 Localization denotes secretion
T840 1591-1600 Localization denotes secretion
T841 1725-1730 Protein denotes IL-1β
T842 1792-1797 Protein denotes NF-κB
T843 1823-1827 Protein denotes CFTR
T844 1731-1741 Gene_expression denotes production
T845 1760-1763 Positive_regulation denotes due
T846 1780-1788 Positive_regulation denotes increase
T847 1815-1819 Negative_regulation denotes loss
T848 1715-1724 Positive_regulation denotes increased
R667 T802 T804 themeOf Interleukin-1 beta,mediator
R668 T803 T805 themeOf IL-1β,mediator
R669 T806 T807 themeOf IL-1β,Secretion
R670 T809 T811 themeOf IL-1β,produce
R671 T810 T812 themeOf caspase-1,upregulate
R672 T813 T815 themeOf IL-1β,produced
R673 T814 T816 themeOf caspase-1,upregulated
R674 T816 T817 themeOf upregulated,amounts
R675 T818 T820 themeOf caspase-1,activation
R676 T819 T821 themeOf IL-1β,production
R677 T821 T822 themeOf production,activation
R678 T823 T825 themeOf IL-1β,production
R679 T825 T826 themeOf production,dependent
R680 T825 T827 themeOf production,enhanced
R681 T828 T831 themeOf CFTR,inhibition
R682 T829 T832 themeOf IL-1β,production
R683 T830 T833 themeOf IL-8,production
R684 T832 T834 themeOf production,alter
R685 T833 T835 themeOf production,alter
R686 T837 T839 themeOf IL-1β,secretion
R687 T838 T840 themeOf CF pathogen Pseudomonas aeruginosa,secretion
R688 T841 T844 themeOf IL-1β,production
R689 T842 T846 themeOf NF-κB,increase
R690 T843 T847 themeOf CFTR,loss
R691 T844 T845 themeOf production,due
R692 T844 T848 themeOf production,increased

events-check-again

Id Subject Object Predicate Lexical cue Negation Speculation
T770 171-189 Protein denotes Interleukin-1 beta
T771 191-196 Protein denotes IL-1β
T772 230-239 Localization denotes Secretion
T773 263-268 Protein denotes IL-1β
T774 269-277 Regulation denotes involves
T775 354-359 Protein denotes IL-1β
T776 443-451 Positive_regulation denotes mediated true
T777 452-457 Protein denotes IL-1β
T778 458-468 Gene_expression denotes production
T779 590-597 Gene_expression denotes produce true
T780 629-639 Positive_regulation denotes stimulated
T781 640-645 Protein denotes IL-1β
T782 868-876 Gene_expression denotes produced
T783 894-899 Protein denotes IL-1β
T784 944-948 Positive_regulation denotes upon
T785 1064-1069 Protein denotes IL-1β
T786 1070-1080 Gene_expression denotes production
T787 1086-1096 Positive_regulation denotes stimulated
T788 1132-1137 Protein denotes IL-1β
T789 1325-1330 Regulation denotes alter true
T790 1331-1336 Protein denotes IL-1β
T791 1345-1355 Gene_expression denotes production
T792 1356-1370 Positive_regulation denotes in response to
T793 1470-1477 Positive_regulation denotes induced
T794 1495-1500 Protein denotes IL-1β
T795 1547-1556 Positive_regulation denotes preserved
T796 1585-1590 Protein denotes IL-1β
T797 1591-1600 Localization denotes secretion
T798 1715-1724 Positive_regulation denotes increased
T799 1724-1730 Protein denotes IL-1β
T800 1731-1741 Gene_expression denotes production
T801 1760-1763 Positive_regulation denotes due true
R647 T771 T770 equivalentTo IL-1β,Interleukin-1 beta
R648 T772 T774 themeOf Secretion,involves
R649 T773 T772 themeOf IL-1β,Secretion
R650 T777 T778 themeOf IL-1β,production
R651 T778 T776 themeOf production,mediated
R652 T779 T780 themeOf produce,stimulated
R653 T781 T779 themeOf IL-1β,produce
R654 T782 T784 themeOf produced,upon
R655 T783 T782 themeOf IL-1β,produced
R656 T785 T786 themeOf IL-1β,production
R657 T786 T787 themeOf production,stimulated
R658 T790 T791 themeOf IL-1β,production
R659 T791 T792 themeOf production,in response to
R660 T792 T789 themeOf in response to,alter
R661 T794 T793 themeOf IL-1β,induced
R662 T796 T797 themeOf IL-1β,secretion
R663 T797 T795 themeOf secretion,preserved
R664 T798 T801 themeOf increased,due
R665 T799 T800 themeOf IL-1β,production
R666 T800 T798 themeOf production,increased

ICD10

Id Subject Object Predicate Lexical cue
T694 149-164 http://purl.bioontology.org/ontology/ICD10/E84 denotes cystic fibrosis
T695 149-164 http://purl.bioontology.org/ontology/ICD10/E84.9 denotes cystic fibrosis

GO-CC

Id Subject Object Predicate Lexical cue
T688 496-500 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T689 565-569 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T690 672-677 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T691 812-817 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T692 1297-1302 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T693 1412-1417 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

GO-MF

Id Subject Object Predicate Lexical cue
T696 1340-1344 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8

GO-BP

Id Subject Object Predicate Lexical cue
T680 11-23 http://purl.obolibrary.org/obo/GO_0006954 denotes Inflammation
T681 171-189 http://purl.obolibrary.org/obo/GO_0050720 denotes Interleukin-1 beta
T682 171-189 http://purl.obolibrary.org/obo/GO_0050702 denotes Interleukin-1 beta
T683 183-193 http://purl.obolibrary.org/obo/GO_0032611 denotes 1 beta (IL
T684 230-239 http://purl.obolibrary.org/obo/GO_0046903 denotes Secretion
T685 1591-1600 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T686 1340-1355 http://purl.obolibrary.org/obo/GO_0032677 denotes IL-8 production
T687 1340-1355 http://purl.obolibrary.org/obo/GO_0032637 denotes IL-8 production

UBERON-AE

Id Subject Object Predicate Lexical cue
T36 794-799 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T386 0-10 NNP denotes Background
T387 11-23 NNP denotes Inflammation
T388 24-27 CC denotes and
T389 28-37 NN denotes infection
T390 38-41 VBP denotes are
T391 42-47 JJ denotes major
T392 48-60 NNS denotes determinants
T393 61-63 IN denotes of
T394 64-71 NN denotes disease
T395 72-80 NN denotes severity
T396 81-84 CC denotes and
T397 85-97 RB denotes consequently
T398 97-98 , denotes ,
T399 99-102 DT denotes the
T400 103-110 NN denotes quality
T401 111-113 IN denotes of
T402 114-118 NN denotes life
T403 119-122 CC denotes and
T404 123-130 NN denotes outcome
T405 131-134 IN denotes for
T406 135-143 NNS denotes patients
T407 144-148 IN denotes with
T408 149-155 JJ denotes cystic
T409 156-164 NN denotes fibrosis
T410 165-166 -LRB- denotes (
T411 166-168 NNP denotes CF
T412 168-169 -RRB- denotes )
T413 169-170 . denotes .
T414 171-184 NN denotes Interleukin-1
T415 185-189 NN denotes beta
T416 190-191 -LRB- denotes (
T417 191-196 NN denotes IL-1β
T418 196-197 -RRB- denotes )
T419 198-200 VBZ denotes is
T420 201-202 DT denotes a
T421 203-206 JJ denotes key
T422 207-219 JJ denotes inflammatory
T423 220-228 NN denotes mediator
T424 228-229 . denotes .
T425 230-239 NNP denotes Secretion
T426 240-242 IN denotes of
T427 243-255 RB denotes biologically
T428 256-262 JJ denotes active
T429 263-268 JJ denotes IL-1β
T430 269-277 VBZ denotes involves
T431 278-299 JJ denotes inflammasome-mediated
T432 300-310 NN denotes processing
T433 310-311 . denotes .
T434 312-318 NNP denotes Little
T435 319-321 VBZ denotes is
T436 322-327 VBN denotes known
T437 328-333 IN denotes about
T438 334-337 DT denotes the
T439 338-350 NN denotes contribution
T440 351-353 IN denotes of
T441 354-359 NN denotes IL-1β
T442 360-363 CC denotes and
T443 364-367 DT denotes the
T444 368-381 NNS denotes inflammasomes
T445 382-384 IN denotes in
T446 385-387 NNP denotes CF
T447 388-400 JJ denotes inflammatory
T448 401-408 NN denotes disease
T449 408-409 . denotes .
T450 410-414 DT denotes This
T451 415-420 NN denotes study
T452 421-429 VBZ denotes examines
T453 430-451 JJ denotes inflammasome-mediated
T454 452-457 JJ denotes IL-1β
T455 458-468 NN denotes production
T456 469-471 IN denotes in
T457 472-474 NNP denotes CF
T458 475-484 JJ denotes bronchial
T459 485-495 JJ denotes epithelial
T460 496-500 NN denotes cell
T461 501-506 NNS denotes lines
T462 507-510 CC denotes and
T463 511-516 JJ denotes human
T464 517-525 NNS denotes patients
T465 526-530 IN denotes with
T466 531-534 NNP denotes CF.
T467 536-543 NNS denotes Results
T468 544-553 NNP denotes Bronchial
T469 554-564 JJ denotes epithelial
T470 565-569 NN denotes cell
T471 570-575 NNS denotes lines
T472 576-580 VBD denotes were
T473 581-586 VBN denotes found
T474 587-589 TO denotes to
T475 590-597 VB denotes produce
T476 598-608 JJ denotes negligible
T477 609-616 NNS denotes amounts
T478 617-619 IN denotes of
T479 620-625 NN denotes basal
T480 626-628 CC denotes or
T481 629-639 VBN denotes stimulated
T482 640-645 NN denotes IL-1β
T483 646-654 VBN denotes compared
T484 655-657 TO denotes to
T485 658-671 JJ denotes hematopoeitic
T486 672-677 NNS denotes cells
T487 678-681 CC denotes and
T488 682-686 PRP denotes they
T489 687-690 VBD denotes did
T490 691-694 RB denotes not
T491 695-708 RB denotes significantly
T492 709-719 VB denotes upregulate
T493 720-729 JJ denotes caspase-1
T494 730-738 NN denotes activity
T495 739-743 IN denotes upon
T496 744-756 JJ denotes inflammasome
T497 757-768 NN denotes stimulation
T498 768-769 . denotes .
T499 770-772 IN denotes In
T500 773-781 NN denotes contrast
T501 781-782 , denotes ,
T502 783-793 JJ denotes peripheral
T503 794-799 NN denotes blood
T504 800-811 NN denotes mononuclear
T505 812-817 NNS denotes cells
T506 818-819 -LRB- denotes (
T507 819-824 NNS denotes PBMCs
T508 824-825 -RRB- denotes )
T509 826-830 IN denotes from
T510 831-835 DT denotes both
T511 836-838 NNP denotes CF
T512 839-842 CC denotes and
T513 843-850 JJ denotes healthy
T514 851-858 NN denotes control
T515 859-867 NNS denotes subjects
T516 868-876 VBD denotes produced
T517 877-882 JJ denotes large
T518 883-890 NNS denotes amounts
T519 891-893 IN denotes of
T520 894-899 NN denotes IL-1β
T521 900-903 CC denotes and
T522 904-912 RB denotes strongly
T523 913-924 VBD denotes upregulated
T524 925-934 JJ denotes caspase-1
T525 935-943 NN denotes activity
T526 944-948 IN denotes upon
T527 949-961 JJ denotes inflammasome
T528 962-973 NN denotes stimulation
T529 973-974 . denotes .
T530 975-980 NNS denotes PBMCs
T531 981-985 IN denotes from
T532 986-988 NNP denotes CF
T533 989-997 NNS denotes patients
T534 998-1001 CC denotes and
T535 1002-1010 NNS denotes controls
T536 1011-1020 VBD denotes displayed
T537 1021-1028 JJ denotes similar
T538 1029-1035 NNS denotes levels
T539 1036-1038 IN denotes of
T540 1039-1048 JJ denotes caspase-1
T541 1049-1059 NN denotes activation
T542 1060-1063 CC denotes and
T543 1064-1069 JJ denotes IL-1β
T544 1070-1080 NN denotes production
T545 1081-1085 WRB denotes when
T546 1086-1096 VBN denotes stimulated
T547 1097-1101 IN denotes with
T548 1102-1114 JJ denotes inflammasome
T549 1115-1125 NNS denotes activators
T550 1125-1126 . denotes .
T551 1127-1131 DT denotes This
T552 1132-1137 JJ denotes IL-1β
T553 1138-1148 NN denotes production
T554 1149-1152 VBD denotes was
T555 1153-1162 JJ denotes dependent
T556 1163-1165 IN denotes on
T557 1166-1171 JJ denotes NF-κB
T558 1172-1180 NN denotes activity
T559 1181-1184 CC denotes and
T560 1185-1190 MD denotes could
T561 1191-1193 VB denotes be
T562 1194-1202 VBN denotes enhanced
T563 1203-1205 IN denotes by
T564 1206-1213 VBG denotes priming
T565 1214-1218 IN denotes with
T566 1219-1222 NNP denotes LPS
T567 1222-1223 . denotes .
T568 1224-1231 RB denotes Finally
T569 1231-1232 , denotes ,
T570 1233-1241 NN denotes chemical
T571 1242-1252 NN denotes inhibition
T572 1253-1255 IN denotes of
T573 1256-1260 NNP denotes CFTR
T574 1261-1269 NN denotes activity
T575 1270-1272 IN denotes in
T576 1273-1280 NN denotes control
T577 1281-1286 NNS denotes PBMCs
T578 1287-1290 CC denotes and
T579 1291-1296 CD denotes THP-1
T580 1297-1302 NNS denotes cells
T581 1303-1306 VBD denotes did
T582 1307-1310 RB denotes not
T583 1311-1324 RB denotes significantly
T584 1325-1330 VB denotes alter
T585 1331-1336 JJ denotes IL-1β
T586 1337-1339 CC denotes or
T587 1340-1344 JJ denotes IL-8
T588 1345-1355 NN denotes production
T589 1356-1358 IN denotes in
T590 1359-1367 NN denotes response
T591 1368-1370 TO denotes to
T592 1371-1373 NNP denotes P.
T593 1374-1384 NN denotes aeruginosa
T594 1384-1385 . denotes .
T595 1387-1397 NNP denotes Conclusion
T596 1398-1411 NNP denotes Hematopoeitic
T597 1412-1417 NNS denotes cells
T598 1418-1424 VBP denotes appear
T599 1425-1427 TO denotes to
T600 1428-1430 VB denotes be
T601 1431-1434 DT denotes the
T602 1435-1446 JJ denotes predominant
T603 1447-1453 NN denotes source
T604 1454-1456 IN denotes of
T605 1457-1477 JJ denotes inflammasome-induced
T606 1478-1494 JJ denotes pro-inflammatory
T607 1495-1500 NN denotes IL-1β
T608 1501-1503 IN denotes in
T609 1504-1507 NNP denotes CF.
T610 1508-1513 NNP denotes PBMCs
T611 1514-1521 VBD denotes derived
T612 1522-1526 IN denotes from
T613 1527-1529 NNP denotes CF
T614 1530-1538 NNS denotes subjects
T615 1539-1546 VBP denotes display
T616 1547-1556 VBN denotes preserved
T617 1557-1569 JJ denotes inflammasome
T618 1570-1580 NN denotes activation
T619 1581-1584 CC denotes and
T620 1585-1590 JJ denotes IL-1β
T621 1591-1600 NN denotes secretion
T622 1601-1603 IN denotes in
T623 1604-1612 NN denotes response
T624 1613-1615 TO denotes to
T625 1616-1619 DT denotes the
T626 1620-1625 JJ denotes major
T627 1626-1628 NNP denotes CF
T628 1629-1637 NN denotes pathogen
T629 1638-1649 NNP denotes Pseudomonas
T630 1650-1660 NN denotes aeruginosa
T631 1660-1661 . denotes .
T632 1662-1669 RB denotes However
T633 1669-1670 , denotes ,
T634 1671-1674 PRP$ denotes our
T635 1675-1679 NNS denotes data
T636 1680-1682 VBP denotes do
T637 1683-1686 RB denotes not
T638 1687-1694 VB denotes support
T639 1695-1698 DT denotes the
T640 1699-1709 NN denotes hypothesis
T641 1710-1714 WDT denotes that
T642 1715-1724 VBD denotes increased
T643 1725-1730 JJ denotes IL-1β
T644 1731-1741 NN denotes production
T645 1742-1744 IN denotes in
T646 1745-1747 NNP denotes CF
T647 1748-1756 NNS denotes subjects
T648 1757-1759 VBZ denotes is
T649 1760-1763 JJ denotes due
T650 1764-1766 TO denotes to
T651 1767-1769 DT denotes an
T652 1770-1779 JJ denotes intrinsic
T653 1780-1788 NN denotes increase
T654 1789-1791 IN denotes in
T655 1792-1797 JJ denotes NF-κB
T656 1798-1806 NN denotes activity
T657 1807-1814 IN denotes through
T658 1815-1819 NN denotes loss
T659 1820-1822 IN denotes of
T660 1823-1827 NNP denotes CFTR
T661 1828-1836 NN denotes function
T662 1836-1837 . denotes .
R324 T386 T387 compound Background,Inflammation
R326 T388 T387 cc and,Inflammation
R327 T389 T387 conj infection,Inflammation
R328 T390 T390 ROOT are,are
R329 T391 T392 amod major,determinants
R330 T392 T390 attr determinants,are
R331 T393 T392 prep of,determinants
R332 T394 T395 compound disease,severity
R333 T395 T393 pobj severity,of
R334 T396 T390 cc and,are
R335 T397 T400 advmod consequently,quality
R336 T398 T400 punct ",",quality
R337 T399 T400 det the,quality
R338 T400 T390 conj quality,are
R339 T401 T400 prep of,quality
R340 T402 T401 pobj life,of
R341 T403 T402 cc and,life
R342 T404 T400 conj outcome,quality
R343 T405 T400 prep for,quality
R344 T406 T405 pobj patients,for
R345 T407 T406 prep with,patients
R346 T408 T409 compound cystic,fibrosis
R347 T409 T407 pobj fibrosis,with
R348 T410 T411 punct (,CF
R349 T411 T409 appos CF,fibrosis
R350 T412 T400 punct ),quality
R351 T413 T390 punct .,are
R352 T414 T415 compound Interleukin-1,beta
R353 T415 T419 nsubj beta,is
R354 T416 T417 punct (,IL-1β
R355 T417 T415 appos IL-1β,beta
R356 T418 T417 punct ),IL-1β
R357 T419 T419 ROOT is,is
R358 T420 T423 det a,mediator
R359 T421 T423 amod key,mediator
R360 T422 T423 amod inflammatory,mediator
R361 T423 T419 attr mediator,is
R362 T424 T419 punct .,is
R363 T425 T430 nsubj Secretion,involves
R364 T426 T425 prep of,Secretion
R365 T427 T428 advmod biologically,active
R366 T428 T429 amod active,IL-1β
R367 T429 T426 pobj IL-1β,of
R368 T430 T430 ROOT involves,involves
R369 T431 T432 amod inflammasome-mediated,processing
R370 T432 T430 dobj processing,involves
R371 T433 T430 punct .,involves
R372 T434 T436 nsubjpass Little,known
R373 T435 T436 auxpass is,known
R374 T436 T436 ROOT known,known
R375 T437 T436 prep about,known
R376 T438 T439 det the,contribution
R377 T439 T437 pobj contribution,about
R378 T440 T439 prep of,contribution
R379 T441 T440 pobj IL-1β,of
R380 T442 T441 cc and,IL-1β
R381 T443 T444 det the,inflammasomes
R382 T444 T441 conj inflammasomes,IL-1β
R383 T445 T444 prep in,inflammasomes
R384 T446 T448 nmod CF,disease
R385 T447 T448 amod inflammatory,disease
R386 T448 T445 pobj disease,in
R387 T449 T436 punct .,known
R388 T450 T451 det This,study
R389 T451 T452 nsubj study,examines
R390 T452 T452 ROOT examines,examines
R391 T453 T455 amod inflammasome-mediated,production
R392 T454 T455 compound IL-1β,production
R393 T455 T452 dobj production,examines
R394 T456 T455 prep in,production
R395 T457 T461 nmod CF,lines
R396 T458 T461 amod bronchial,lines
R397 T459 T461 amod epithelial,lines
R398 T460 T461 compound cell,lines
R399 T461 T456 pobj lines,in
R400 T462 T461 cc and,lines
R401 T463 T464 amod human,patients
R402 T464 T461 conj patients,lines
R403 T465 T455 prep with,production
R404 T466 T467 compound CF.,Results
R405 T467 T473 nsubjpass Results,found
R406 T468 T471 nmod Bronchial,lines
R407 T469 T471 amod epithelial,lines
R408 T470 T471 compound cell,lines
R409 T471 T473 nsubjpass lines,found
R410 T472 T473 auxpass were,found
R411 T473 T452 conj found,examines
R412 T474 T475 aux to,produce
R413 T475 T473 xcomp produce,found
R414 T476 T477 amod negligible,amounts
R415 T477 T475 dobj amounts,produce
R416 T478 T477 prep of,amounts
R417 T479 T478 pobj basal,of
R418 T480 T477 cc or,amounts
R419 T481 T482 amod stimulated,IL-1β
R420 T482 T477 conj IL-1β,amounts
R421 T483 T473 prep compared,found
R422 T484 T483 prep to,compared
R423 T485 T486 amod hematopoeitic,cells
R424 T486 T484 pobj cells,to
R425 T487 T473 cc and,found
R426 T488 T492 nsubj they,upregulate
R427 T489 T492 aux did,upregulate
R428 T490 T492 neg not,upregulate
R429 T491 T492 advmod significantly,upregulate
R430 T492 T473 conj upregulate,found
R431 T493 T494 amod caspase-1,activity
R432 T494 T492 dobj activity,upregulate
R433 T495 T492 prep upon,upregulate
R434 T496 T497 amod inflammasome,stimulation
R435 T497 T495 pobj stimulation,upon
R436 T498 T452 punct .,examines
R437 T499 T516 prep In,produced
R438 T500 T499 pobj contrast,In
R439 T501 T516 punct ",",produced
R440 T502 T505 amod peripheral,cells
R441 T503 T504 compound blood,mononuclear
R442 T504 T505 compound mononuclear,cells
R443 T505 T516 nsubj cells,produced
R444 T506 T505 punct (,cells
R445 T507 T505 appos PBMCs,cells
R446 T508 T505 punct ),cells
R447 T509 T505 prep from,cells
R448 T510 T511 preconj both,CF
R449 T511 T509 pobj CF,from
R450 T512 T511 cc and,CF
R451 T513 T515 amod healthy,subjects
R452 T514 T515 compound control,subjects
R453 T515 T511 conj subjects,CF
R454 T516 T516 ROOT produced,produced
R455 T517 T518 amod large,amounts
R456 T518 T516 dobj amounts,produced
R457 T519 T518 prep of,amounts
R458 T520 T519 pobj IL-1β,of
R459 T521 T516 cc and,produced
R460 T522 T523 advmod strongly,upregulated
R461 T523 T516 conj upregulated,produced
R462 T524 T525 amod caspase-1,activity
R463 T525 T523 dobj activity,upregulated
R464 T526 T523 prep upon,upregulated
R465 T527 T528 amod inflammasome,stimulation
R466 T528 T526 pobj stimulation,upon
R467 T529 T516 punct .,produced
R468 T530 T536 nsubj PBMCs,displayed
R469 T531 T530 prep from,PBMCs
R470 T532 T533 compound CF,patients
R471 T533 T531 pobj patients,from
R472 T534 T533 cc and,patients
R473 T535 T533 conj controls,patients
R474 T536 T536 ROOT displayed,displayed
R475 T537 T538 amod similar,levels
R476 T538 T536 dobj levels,displayed
R477 T539 T538 prep of,levels
R478 T540 T541 amod caspase-1,activation
R479 T541 T539 pobj activation,of
R480 T542 T541 cc and,activation
R481 T543 T544 amod IL-1β,production
R482 T544 T541 conj production,activation
R483 T545 T546 advmod when,stimulated
R484 T546 T536 advcl stimulated,displayed
R485 T547 T546 prep with,stimulated
R486 T548 T549 amod inflammasome,activators
R487 T549 T547 pobj activators,with
R488 T550 T536 punct .,displayed
R489 T551 T553 det This,production
R490 T552 T553 compound IL-1β,production
R491 T553 T554 nsubj production,was
R492 T554 T554 ROOT was,was
R493 T555 T554 acomp dependent,was
R494 T556 T555 prep on,dependent
R495 T557 T558 amod NF-κB,activity
R496 T558 T556 pobj activity,on
R497 T559 T554 cc and,was
R498 T560 T562 aux could,enhanced
R499 T561 T562 auxpass be,enhanced
R500 T562 T554 conj enhanced,was
R501 T563 T562 prep by,enhanced
R502 T564 T563 pcomp priming,by
R503 T565 T564 prep with,priming
R504 T566 T565 pobj LPS,with
R505 T567 T554 punct .,was
R506 T568 T584 advmod Finally,alter
R507 T569 T584 punct ",",alter
R508 T570 T571 compound chemical,inhibition
R509 T571 T584 nsubj inhibition,alter
R510 T572 T571 prep of,inhibition
R511 T573 T574 amod CFTR,activity
R512 T574 T572 pobj activity,of
R513 T575 T574 prep in,activity
R514 T576 T575 pobj control,in
R515 T577 T571 conj PBMCs,inhibition
R516 T578 T577 cc and,PBMCs
R517 T579 T580 nummod THP-1,cells
R518 T580 T577 conj cells,PBMCs
R519 T581 T584 aux did,alter
R520 T582 T584 neg not,alter
R521 T583 T584 advmod significantly,alter
R522 T584 T584 ROOT alter,alter
R523 T585 T588 amod IL-1β,production
R524 T586 T585 cc or,IL-1β
R525 T587 T585 conj IL-8,IL-1β
R526 T588 T584 dobj production,alter
R527 T589 T584 prep in,alter
R528 T590 T589 pobj response,in
R529 T591 T590 prep to,response
R530 T592 T593 compound P.,aeruginosa
R531 T593 T591 pobj aeruginosa,to
R532 T594 T584 punct .,alter
R533 T595 T596 compound Conclusion,Hematopoeitic
R534 T596 T597 compound Hematopoeitic,cells
R535 T597 T598 nsubj cells,appear
R536 T598 T598 ROOT appear,appear
R537 T599 T600 aux to,be
R538 T600 T598 xcomp be,appear
R539 T601 T603 det the,source
R540 T602 T603 amod predominant,source
R541 T603 T600 attr source,be
R542 T604 T603 prep of,source
R543 T605 T607 amod inflammasome-induced,IL-1β
R544 T606 T607 amod pro-inflammatory,IL-1β
R545 T607 T604 pobj IL-1β,of
R546 T608 T607 prep in,IL-1β
R547 T609 T610 compound CF.,PBMCs
R548 T610 T608 pobj PBMCs,in
R549 T611 T598 advcl derived,appear
R550 T612 T611 prep from,derived
R551 T613 T614 compound CF,subjects
R552 T614 T612 pobj subjects,from
R553 T615 T611 dobj display,derived
R554 T616 T618 amod preserved,activation
R555 T617 T618 amod inflammasome,activation
R556 T618 T615 dobj activation,display
R557 T619 T618 cc and,activation
R558 T620 T621 amod IL-1β,secretion
R559 T621 T618 conj secretion,activation
R560 T622 T615 prep in,display
R561 T623 T622 pobj response,in
R562 T624 T623 prep to,response
R563 T625 T628 det the,pathogen
R564 T626 T628 amod major,pathogen
R565 T627 T628 compound CF,pathogen
R566 T628 T624 pobj pathogen,to
R567 T629 T630 compound Pseudomonas,aeruginosa
R568 T630 T628 appos aeruginosa,pathogen
R569 T631 T598 punct .,appear
R570 T632 T638 advmod However,support
R571 T633 T638 punct ",",support
R572 T634 T635 poss our,data
R573 T635 T638 nsubj data,support
R574 T636 T638 aux do,support
R575 T637 T638 neg not,support
R576 T638 T638 ROOT support,support
R577 T639 T640 det the,hypothesis
R578 T640 T638 dobj hypothesis,support
R579 T641 T642 nsubj that,increased
R580 T642 T640 relcl increased,hypothesis
R581 T643 T644 amod IL-1β,production
R582 T644 T642 dobj production,increased
R583 T645 T644 prep in,production
R584 T646 T647 compound CF,subjects
R585 T647 T645 pobj subjects,in
R586 T648 T638 advcl is,support
R587 T649 T648 acomp due,is
R588 T650 T649 prep to,due
R589 T651 T653 det an,increase
R590 T652 T653 amod intrinsic,increase
R591 T653 T650 pobj increase,to
R592 T654 T653 prep in,increase
R593 T655 T656 amod NF-κB,activity
R594 T656 T654 pobj activity,in
R595 T657 T653 prep through,increase
R596 T658 T657 pobj loss,through
R597 T659 T658 prep of,loss
R598 T660 T661 amod CFTR,function
R599 T661 T659 pobj function,of
R600 T662 T638 punct .,support

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T97 0-10 NN denotes Background
T98 11-23 NN denotes Inflammation
T99 24-27 CC denotes and
T100 28-37 NN denotes infection
T101 38-41 VB denotes are
T102 42-47 JJ denotes major
T103 48-60 NN denotes determinants
T104 61-63 IN denotes of
T105 64-71 NN denotes disease
T106 72-80 NN denotes severity
T107 81-84 CC denotes and
T108 85-97 RB denotes consequently
T109 97-98 -COMMA- denotes ,
T110 99-102 DT denotes the
T111 103-110 NN denotes quality
T112 111-113 IN denotes of
T113 114-118 NN denotes life
T114 119-122 CC denotes and
T115 123-130 NN denotes outcome
T116 131-134 IN denotes for
T117 135-143 NN denotes patients
T118 144-148 IN denotes with
T119 149-155 JJ denotes cystic
T120 156-164 NN denotes fibrosis
T121 165-166 -LRB- denotes (
T122 166-168 NN denotes CF
T123 168-169 -RRB- denotes )
T124 171-184 NN denotes Interleukin-1
T125 185-189 NN denotes beta
T126 190-191 -LRB- denotes (
T127 191-196 NN denotes IL-1β
T128 196-197 -RRB- denotes )
T129 198-200 VB denotes is
T130 201-202 DT denotes a
T131 203-206 JJ denotes key
T132 207-219 JJ denotes inflammatory
T133 220-228 NN denotes mediator
T134 230-239 NN denotes Secretion
T135 240-242 IN denotes of
T136 243-255 RB denotes biologically
T137 256-262 JJ denotes active
T138 263-268 NN denotes IL-1β
T139 269-277 VB denotes involves
T140 278-299 JJ denotes inflammasome-mediated
T141 300-310 NN denotes processing
T142 312-318 JJ denotes Little
T143 319-321 VB denotes is
T144 322-327 VB denotes known
T145 328-333 IN denotes about
T146 334-337 DT denotes the
T147 338-350 NN denotes contribution
T148 351-353 IN denotes of
T149 354-359 NN denotes IL-1β
T150 360-363 CC denotes and
T151 364-367 DT denotes the
T152 368-381 NN denotes inflammasomes
T153 382-384 IN denotes in
T154 385-387 NN denotes CF
T155 388-400 JJ denotes inflammatory
T156 401-408 NN denotes disease
T157 410-414 DT denotes This
T158 415-420 NN denotes study
T159 421-429 VB denotes examines
T160 430-451 JJ denotes inflammasome-mediated
T161 452-457 NN denotes IL-1β
T162 458-468 NN denotes production
T163 469-471 IN denotes in
T164 472-474 NN denotes CF
T165 475-484 JJ denotes bronchial
T166 485-495 JJ denotes epithelial
T167 496-500 NN denotes cell
T168 501-506 NN denotes lines
T169 507-510 CC denotes and
T170 511-516 JJ denotes human
T171 517-525 NN denotes patients
T172 526-530 IN denotes with
T173 531-533 NN denotes CF
T174 536-543 NN denotes Results
T175 544-553 JJ denotes Bronchial
T176 554-564 JJ denotes epithelial
T177 565-569 NN denotes cell
T178 570-575 NN denotes lines
T179 576-580 VB denotes were
T180 581-586 VB denotes found
T181 587-589 TO denotes to
T182 590-597 VB denotes produce
T183 598-608 JJ denotes negligible
T184 609-616 NN denotes amounts
T185 617-619 IN denotes of
T186 620-625 JJ denotes basal
T187 626-628 CC denotes or
T188 629-639 VB denotes stimulated
T189 640-645 NN denotes IL-1β
T190 646-654 VB denotes compared
T191 655-657 TO denotes to
T192 658-671 JJ denotes hematopoeitic
T193 672-677 NN denotes cells
T194 678-681 CC denotes and
T195 682-686 PRP denotes they
T196 687-690 VB denotes did
T197 691-694 RB denotes not
T198 695-708 RB denotes significantly
T199 709-719 VB denotes upregulate
T200 720-729 NN denotes caspase-1
T201 730-738 NN denotes activity
T202 739-743 IN denotes upon
T203 744-756 JJ denotes inflammasome
T204 757-768 NN denotes stimulation
T205 770-772 IN denotes In
T206 773-781 NN denotes contrast
T207 781-782 -COMMA- denotes ,
T208 783-793 JJ denotes peripheral
T209 794-799 NN denotes blood
T210 800-811 JJ denotes mononuclear
T211 812-817 NN denotes cells
T212 818-819 -LRB- denotes (
T213 819-824 NN denotes PBMCs
T214 824-825 -RRB- denotes )
T215 826-830 IN denotes from
T216 831-835 CC denotes both
T217 836-838 NN denotes CF
T218 839-842 CC denotes and
T219 843-850 JJ denotes healthy
T220 851-858 NN denotes control
T221 859-867 NN denotes subjects
T222 868-876 VB denotes produced
T223 877-882 JJ denotes large
T224 883-890 NN denotes amounts
T225 891-893 IN denotes of
T226 894-899 NN denotes IL-1β
T227 900-903 CC denotes and
T228 904-912 RB denotes strongly
T229 913-924 VB denotes upregulated
T230 925-934 NN denotes caspase-1
T231 935-943 NN denotes activity
T232 944-948 IN denotes upon
T233 949-961 JJ denotes inflammasome
T234 962-973 NN denotes stimulation
T235 975-980 NN denotes PBMCs
T236 981-985 IN denotes from
T237 986-988 NN denotes CF
T238 989-997 NN denotes patients
T239 998-1001 CC denotes and
T240 1002-1010 NN denotes controls
T241 1011-1020 VB denotes displayed
T242 1021-1028 JJ denotes similar
T243 1029-1035 NN denotes levels
T244 1036-1038 IN denotes of
T245 1039-1048 NN denotes caspase-1
T246 1049-1059 NN denotes activation
T247 1060-1063 CC denotes and
T248 1064-1069 NN denotes IL-1β
T249 1070-1080 NN denotes production
T250 1081-1085 WRB denotes when
T251 1086-1096 VB denotes stimulated
T252 1097-1101 IN denotes with
T253 1102-1114 JJ denotes inflammasome
T254 1115-1125 NN denotes activators
T255 1127-1131 DT denotes This
T256 1132-1137 NN denotes IL-1β
T257 1138-1148 NN denotes production
T258 1149-1152 VB denotes was
T259 1153-1162 JJ denotes dependent
T260 1163-1165 IN denotes on
T261 1166-1171 NN denotes NF-κB
T262 1172-1180 NN denotes activity
T263 1181-1184 CC denotes and
T264 1185-1190 MD denotes could
T265 1191-1193 VB denotes be
T266 1194-1202 VB denotes enhanced
T267 1203-1205 IN denotes by
T268 1206-1213 VB denotes priming
T269 1214-1218 IN denotes with
T270 1219-1222 NN denotes LPS
T271 1224-1231 RB denotes Finally
T272 1231-1232 -COMMA- denotes ,
T273 1233-1241 JJ denotes chemical
T274 1242-1252 NN denotes inhibition
T275 1253-1255 IN denotes of
T276 1256-1260 NN denotes CFTR
T277 1261-1269 NN denotes activity
T278 1270-1272 IN denotes in
T279 1273-1280 NN denotes control
T280 1281-1286 NN denotes PBMCs
T281 1287-1290 CC denotes and
T282 1291-1296 NN denotes THP-1
T283 1297-1302 NN denotes cells
T284 1303-1306 VB denotes did
T285 1307-1310 RB denotes not
T286 1311-1324 RB denotes significantly
T287 1325-1330 VB denotes alter
T288 1331-1336 NN denotes IL-1β
T289 1337-1339 CC denotes or
T290 1340-1344 NN denotes IL-8
T291 1345-1355 NN denotes production
T292 1356-1358 IN denotes in
T293 1359-1367 NN denotes response
T294 1368-1370 TO denotes to
T295 1371-1373 NNP denotes P.
T296 1374-1384 NN denotes aeruginosa
T297 1387-1397 NN denotes Conclusion
T298 1398-1411 JJ denotes Hematopoeitic
T299 1412-1417 NN denotes cells
T300 1418-1424 VB denotes appear
T301 1425-1427 TO denotes to
T302 1428-1430 VB denotes be
T303 1431-1434 DT denotes the
T304 1435-1446 JJ denotes predominant
T305 1447-1453 NN denotes source
T306 1454-1456 IN denotes of
T307 1457-1477 JJ denotes inflammasome-induced
T308 1478-1494 JJ denotes pro-inflammatory
T309 1495-1500 NN denotes IL-1β
T310 1501-1503 IN denotes in
T311 1504-1506 NN denotes CF
T312 1508-1513 NN denotes PBMCs
T313 1514-1521 VB denotes derived
T314 1522-1526 IN denotes from
T315 1527-1529 NN denotes CF
T316 1530-1538 NN denotes subjects
T317 1539-1546 VB denotes display
T318 1547-1556 VB denotes preserved
T319 1557-1569 JJ denotes inflammasome
T320 1570-1580 NN denotes activation
T321 1581-1584 CC denotes and
T322 1585-1590 NN denotes IL-1β
T323 1591-1600 NN denotes secretion
T324 1601-1603 IN denotes in
T325 1604-1612 NN denotes response
T326 1613-1615 TO denotes to
T327 1616-1619 DT denotes the
T328 1620-1625 JJ denotes major
T329 1626-1628 NN denotes CF
T330 1629-1637 NN denotes pathogen
T331 1638-1649 NN denotes Pseudomonas
T332 1650-1660 NN denotes aeruginosa
T333 1662-1669 RB denotes However
T334 1669-1670 -COMMA- denotes ,
T335 1671-1674 PRP-DOLLAR- denotes our
T336 1675-1679 NN denotes data
T337 1680-1682 VB denotes do
T338 1683-1686 RB denotes not
T339 1687-1694 VB denotes support
T340 1695-1698 DT denotes the
T341 1699-1709 NN denotes hypothesis
T342 1710-1714 IN denotes that
T343 1715-1724 VB denotes increased
T344 1725-1730 NN denotes IL-1β
T345 1731-1741 NN denotes production
T346 1742-1744 IN denotes in
T347 1745-1747 NN denotes CF
T348 1748-1756 NN denotes subjects
T349 1757-1759 VB denotes is
T350 1760-1763 JJ denotes due
T351 1764-1766 TO denotes to
T352 1767-1769 DT denotes an
T353 1770-1779 JJ denotes intrinsic
T354 1780-1788 NN denotes increase
T355 1789-1791 IN denotes in
T356 1792-1797 NN denotes NF-κB
T357 1798-1806 NN denotes activity
T358 1807-1814 IN denotes through
T359 1815-1819 NN denotes loss
T360 1820-1822 IN denotes of
T361 1823-1827 NN denotes CFTR
T362 1828-1836 NN denotes function
R52 T98 T99 arg1Of Inflammation,and
R53 T99 T101 arg1Of and,are
R54 T100 T99 arg2Of infection,and
R55 T103 T101 arg2Of determinants,are
R56 T103 T102 arg1Of determinants,major
R57 T103 T104 arg1Of determinants,of
R58 T103 T108 arg1Of determinants,consequently
R59 T103 T109 arg1Of determinants,","
R60 T104 T107 arg1Of of,and
R61 T106 T104 arg2Of severity,of
R62 T106 T105 arg1Of severity,disease
R63 T108 T107 arg2Of consequently,and
R64 T111 T109 arg2Of quality,","
R65 T111 T110 arg1Of quality,the
R66 T111 T112 arg1Of quality,of
R67 T111 T116 arg1Of quality,for
R68 T113 T114 arg1Of life,and
R69 T114 T112 arg2Of and,of
R70 T115 T114 arg2Of outcome,and
R71 T117 T116 arg2Of patients,for
R72 T117 T118 arg1Of patients,with
R73 T120 T118 arg2Of fibrosis,with
R74 T120 T119 arg1Of fibrosis,cystic
R75 T120 T121 arg1Of fibrosis,(
R76 T122 T121 arg2Of CF,(
R77 T123 T121 arg3Of ),(
R78 T125 T124 arg1Of beta,Interleukin-1
R79 T125 T126 arg1Of beta,(
R80 T125 T129 arg1Of beta,is
R81 T127 T126 arg2Of IL-1β,(
R82 T128 T126 arg3Of ),(
R83 T133 T129 arg2Of mediator,is
R84 T133 T130 arg1Of mediator,a
R85 T133 T131 arg1Of mediator,key
R86 T133 T132 arg1Of mediator,inflammatory
R87 T134 T135 arg1Of Secretion,of
R88 T134 T139 arg1Of Secretion,involves
R89 T137 T136 arg1Of active,biologically
R90 T138 T135 arg2Of IL-1β,of
R91 T138 T137 arg1Of IL-1β,active
R92 T141 T139 arg2Of processing,involves
R93 T141 T140 arg1Of processing,inflammasome-mediated
R94 T142 T143 arg1Of Little,is
R95 T142 T144 arg2Of Little,known
R96 T144 T143 arg2Of known,is
R97 T144 T145 arg1Of known,about
R98 T147 T145 arg2Of contribution,about
R99 T147 T146 arg1Of contribution,the
R100 T147 T148 arg1Of contribution,of
R101 T147 T153 arg1Of contribution,in
R102 T149 T150 arg1Of IL-1β,and
R103 T150 T148 arg2Of and,of
R104 T152 T150 arg2Of inflammasomes,and
R105 T152 T151 arg1Of inflammasomes,the
R106 T156 T153 arg2Of disease,in
R107 T156 T154 arg1Of disease,CF
R108 T156 T155 arg1Of disease,inflammatory
R109 T158 T157 arg1Of study,This
R110 T158 T159 arg1Of study,examines
R111 T162 T159 arg2Of production,examines
R112 T162 T160 arg1Of production,inflammasome-mediated
R113 T162 T161 arg1Of production,IL-1β
R114 T162 T163 arg1Of production,in
R115 T168 T164 arg1Of lines,CF
R116 T168 T165 arg1Of lines,bronchial
R117 T168 T166 arg1Of lines,epithelial
R118 T168 T167 arg1Of lines,cell
R119 T168 T169 arg1Of lines,and
R120 T169 T163 arg2Of and,in
R121 T171 T169 arg2Of patients,and
R122 T171 T170 arg1Of patients,human
R123 T171 T172 arg1Of patients,with
R124 T173 T172 arg2Of CF,with
R125 T178 T175 arg1Of lines,Bronchial
R126 T178 T176 arg1Of lines,epithelial
R127 T178 T177 arg1Of lines,cell
R128 T178 T179 arg1Of lines,were
R129 T178 T180 arg2Of lines,found
R130 T178 T182 arg1Of lines,produce
R131 T180 T179 arg2Of found,were
R132 T180 T190 arg1Of found,compared
R133 T180 T194 arg1Of found,and
R134 T182 T180 arg3Of produce,found
R135 T182 T181 arg1Of produce,to
R136 T184 T182 arg2Of amounts,produce
R137 T184 T183 arg1Of amounts,negligible
R138 T184 T185 arg1Of amounts,of
R139 T186 T187 arg1Of basal,or
R140 T186 T188 arg2Of basal,stimulated
R141 T189 T185 arg2Of IL-1β,of
R142 T189 T186 arg1Of IL-1β,basal
R143 T191 T190 arg2Of to,compared
R144 T193 T191 arg2Of cells,to
R145 T193 T192 arg1Of cells,hematopoeitic
R146 T195 T196 arg1Of they,did
R147 T195 T199 arg1Of they,upregulate
R148 T199 T194 arg2Of upregulate,and
R149 T199 T196 arg2Of upregulate,did
R150 T199 T197 arg1Of upregulate,not
R151 T199 T198 arg1Of upregulate,significantly
R152 T199 T202 arg1Of upregulate,upon
R153 T201 T199 arg2Of activity,upregulate
R154 T201 T200 arg1Of activity,caspase-1
R155 T204 T202 arg2Of stimulation,upon
R156 T204 T203 arg1Of stimulation,inflammasome
R157 T206 T205 arg2Of contrast,In
R158 T211 T208 arg1Of cells,peripheral
R159 T211 T209 arg1Of cells,blood
R160 T211 T210 arg1Of cells,mononuclear
R161 T211 T212 arg1Of cells,(
R162 T211 T215 arg1Of cells,from
R163 T211 T222 arg1Of cells,produced
R164 T213 T212 arg2Of PBMCs,(
R165 T214 T212 arg3Of ),(
R166 T221 T215 arg2Of subjects,from
R167 T221 T216 arg1Of subjects,both
R168 T221 T217 arg1Of subjects,CF
R169 T221 T218 arg1Of subjects,and
R170 T221 T219 arg1Of subjects,healthy
R171 T221 T220 arg1Of subjects,control
R172 T222 T205 arg1Of produced,In
R173 T222 T207 arg1Of produced,","
R174 T224 T222 arg2Of amounts,produced
R175 T224 T223 arg1Of amounts,large
R176 T224 T225 arg1Of amounts,of
R177 T226 T227 arg1Of IL-1β,and
R178 T227 T225 arg2Of and,of
R179 T227 T232 arg1Of and,upon
R180 T229 T228 arg1Of upregulated,strongly
R181 T231 T227 arg2Of activity,and
R182 T231 T229 arg2Of activity,upregulated
R183 T231 T230 arg1Of activity,caspase-1
R184 T234 T232 arg2Of stimulation,upon
R185 T234 T233 arg1Of stimulation,inflammasome
R186 T235 T236 arg1Of PBMCs,from
R187 T235 T241 arg1Of PBMCs,displayed
R188 T238 T237 arg1Of patients,CF
R189 T238 T239 arg1Of patients,and
R190 T239 T236 arg2Of and,from
R191 T240 T239 arg2Of controls,and
R192 T241 T250 arg1Of displayed,when
R193 T243 T241 arg2Of levels,displayed
R194 T243 T242 arg1Of levels,similar
R195 T243 T244 arg1Of levels,of
R196 T246 T245 arg1Of activation,caspase-1
R197 T246 T247 arg1Of activation,and
R198 T247 T244 arg2Of and,of
R199 T249 T247 arg2Of production,and
R200 T249 T248 arg1Of production,IL-1β
R201 T251 T250 arg2Of stimulated,when
R202 T251 T252 arg1Of stimulated,with
R203 T254 T252 arg2Of activators,with
R204 T254 T253 arg1Of activators,inflammasome
R205 T257 T255 arg1Of production,This
R206 T257 T256 arg1Of production,IL-1β
R207 T257 T258 arg1Of production,was
R208 T257 T259 arg1Of production,dependent
R209 T257 T264 arg1Of production,could
R210 T257 T265 arg1Of production,be
R211 T257 T266 arg2Of production,enhanced
R212 T258 T263 arg1Of was,and
R213 T259 T258 arg2Of dependent,was
R214 T259 T260 arg1Of dependent,on
R215 T262 T260 arg2Of activity,on
R216 T262 T261 arg1Of activity,NF-κB
R217 T266 T263 arg2Of enhanced,and
R218 T266 T264 arg2Of enhanced,could
R219 T266 T265 arg2Of enhanced,be
R220 T266 T267 arg1Of enhanced,by
R221 T268 T267 arg2Of priming,by
R222 T268 T269 arg1Of priming,with
R223 T270 T269 arg2Of LPS,with
R224 T274 T273 arg1Of inhibition,chemical
R225 T274 T275 arg1Of inhibition,of
R226 T274 T278 arg1Of inhibition,in
R227 T274 T284 arg1Of inhibition,did
R228 T274 T287 arg1Of inhibition,alter
R229 T277 T275 arg2Of activity,of
R230 T277 T276 arg1Of activity,CFTR
R231 T280 T279 arg1Of PBMCs,control
R232 T280 T281 arg1Of PBMCs,and
R233 T281 T278 arg2Of and,in
R234 T283 T281 arg2Of cells,and
R235 T283 T282 arg1Of cells,THP-1
R236 T287 T271 arg1Of alter,Finally
R237 T287 T272 arg1Of alter,","
R238 T287 T284 arg2Of alter,did
R239 T287 T285 arg1Of alter,not
R240 T287 T286 arg1Of alter,significantly
R241 T287 T292 arg1Of alter,in
R242 T288 T289 arg1Of IL-1β,or
R243 T290 T289 arg2Of IL-8,or
R244 T291 T287 arg2Of production,alter
R245 T291 T288 arg1Of production,IL-1β
R246 T291 T290 arg1Of production,IL-8
R247 T293 T292 arg2Of response,in
R248 T293 T294 arg1Of response,to
R249 T296 T294 arg2Of aeruginosa,to
R250 T296 T295 arg1Of aeruginosa,P.
R251 T299 T298 arg1Of cells,Hematopoeitic
R252 T299 T300 arg1Of cells,appear
R253 T299 T302 arg1Of cells,be
R254 T302 T300 arg2Of be,appear
R255 T302 T301 arg1Of be,to
R256 T305 T302 arg2Of source,be
R257 T305 T303 arg1Of source,the
R258 T305 T304 arg1Of source,predominant
R259 T305 T306 arg1Of source,of
R260 T305 T310 arg1Of source,in
R261 T309 T306 arg2Of IL-1β,of
R262 T309 T307 arg1Of IL-1β,inflammasome-induced
R263 T309 T308 arg1Of IL-1β,pro-inflammatory
R264 T311 T310 arg2Of CF,in
R265 T312 T313 arg2Of PBMCs,derived
R266 T312 T317 arg1Of PBMCs,display
R267 T313 T314 arg1Of derived,from
R268 T316 T314 arg2Of subjects,from
R269 T316 T315 arg1Of subjects,CF
R270 T317 T324 arg1Of display,in
R271 T320 T318 arg2Of activation,preserved
R272 T320 T319 arg1Of activation,inflammasome
R273 T320 T321 arg1Of activation,and
R274 T321 T317 arg2Of and,display
R275 T323 T321 arg2Of secretion,and
R276 T323 T322 arg1Of secretion,IL-1β
R277 T324 T326 arg1Of in,to
R278 T325 T324 arg2Of response,in
R279 T332 T324 arg3Of aeruginosa,in
R280 T332 T327 arg1Of aeruginosa,the
R281 T332 T328 arg1Of aeruginosa,major
R282 T332 T329 arg1Of aeruginosa,CF
R283 T332 T330 arg1Of aeruginosa,pathogen
R284 T332 T331 arg1Of aeruginosa,Pseudomonas
R285 T336 T335 arg1Of data,our
R286 T336 T337 arg1Of data,do
R287 T336 T339 arg1Of data,support
R288 T339 T333 arg1Of support,However
R289 T339 T334 arg1Of support,","
R290 T339 T337 arg2Of support,do
R291 T339 T338 arg1Of support,not
R292 T341 T339 arg2Of hypothesis,support
R293 T341 T340 arg1Of hypothesis,the
R294 T345 T343 arg2Of production,increased
R295 T345 T344 arg1Of production,IL-1β
R296 T345 T346 arg1Of production,in
R297 T345 T349 arg1Of production,is
R298 T345 T351 arg1Of production,to
R299 T348 T346 arg2Of subjects,in
R300 T348 T347 arg1Of subjects,CF
R301 T349 T341 arg2Of is,hypothesis
R302 T349 T342 arg1Of is,that
R303 T351 T349 arg2Of to,is
R304 T351 T350 arg1Of to,due
R305 T354 T351 arg2Of increase,to
R306 T354 T352 arg1Of increase,an
R307 T354 T353 arg1Of increase,intrinsic
R308 T354 T355 arg1Of increase,in
R309 T357 T355 arg2Of activity,in
R310 T357 T356 arg1Of activity,NF-κB
R311 T357 T358 arg1Of activity,through
R312 T359 T358 arg2Of loss,through
R313 T359 T360 arg1Of loss,of
R314 T362 T360 arg2Of function,of
R315 T362 T361 arg1Of function,CFTR

sentences

Id Subject Object Predicate Lexical cue
T73 0-10 Sentence denotes Background
T74 11-170 Sentence denotes Inflammation and infection are major determinants of disease severity and consequently, the quality of life and outcome for patients with cystic fibrosis (CF).
T75 171-229 Sentence denotes Interleukin-1 beta (IL-1β) is a key inflammatory mediator.
T76 230-311 Sentence denotes Secretion of biologically active IL-1β involves inflammasome-mediated processing.
T77 312-409 Sentence denotes Little is known about the contribution of IL-1β and the inflammasomes in CF inflammatory disease.
T78 410-534 Sentence denotes This study examines inflammasome-mediated IL-1β production in CF bronchial epithelial cell lines and human patients with CF.
T79 536-543 Sentence denotes Results
T80 544-769 Sentence denotes Bronchial epithelial cell lines were found to produce negligible amounts of basal or stimulated IL-1β compared to hematopoeitic cells and they did not significantly upregulate caspase-1 activity upon inflammasome stimulation.
T81 770-974 Sentence denotes In contrast, peripheral blood mononuclear cells (PBMCs) from both CF and healthy control subjects produced large amounts of IL-1β and strongly upregulated caspase-1 activity upon inflammasome stimulation.
T82 975-1126 Sentence denotes PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators.
T83 1127-1223 Sentence denotes This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS.
T84 1224-1385 Sentence denotes Finally, chemical inhibition of CFTR activity in control PBMCs and THP-1 cells did not significantly alter IL-1β or IL-8 production in response to P. aeruginosa.
T85 1387-1397 Sentence denotes Conclusion
T86 1398-1507 Sentence denotes Hematopoeitic cells appear to be the predominant source of inflammasome-induced pro-inflammatory IL-1β in CF.
T87 1508-1661 Sentence denotes PBMCs derived from CF subjects display preserved inflammasome activation and IL-1β secretion in response to the major CF pathogen Pseudomonas aeruginosa.
T88 1662-1837 Sentence denotes However, our data do not support the hypothesis that increased IL-1β production in CF subjects is due to an intrinsic increase in NF-κB activity through loss of CFTR function.
T3 0-10 Sentence denotes Background
T4 11-170 Sentence denotes Inflammation and infection are major determinants of disease severity and consequently, the quality of life and outcome for patients with cystic fibrosis (CF).
T5 171-229 Sentence denotes Interleukin-1 beta (IL-1β) is a key inflammatory mediator.
T6 230-311 Sentence denotes Secretion of biologically active IL-1β involves inflammasome-mediated processing.
T7 312-409 Sentence denotes Little is known about the contribution of IL-1β and the inflammasomes in CF inflammatory disease.
T8 410-534 Sentence denotes This study examines inflammasome-mediated IL-1β production in CF bronchial epithelial cell lines and human patients with CF.
T9 536-543 Sentence denotes Results
T10 544-769 Sentence denotes Bronchial epithelial cell lines were found to produce negligible amounts of basal or stimulated IL-1β compared to hematopoeitic cells and they did not significantly upregulate caspase-1 activity upon inflammasome stimulation.
T11 770-974 Sentence denotes In contrast, peripheral blood mononuclear cells (PBMCs) from both CF and healthy control subjects produced large amounts of IL-1β and strongly upregulated caspase-1 activity upon inflammasome stimulation.
T12 975-1126 Sentence denotes PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators.
T13 1127-1223 Sentence denotes This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS.
T14 1224-1385 Sentence denotes Finally, chemical inhibition of CFTR activity in control PBMCs and THP-1 cells did not significantly alter IL-1β or IL-8 production in response to P. aeruginosa.
T15 1387-1397 Sentence denotes Conclusion
T16 1398-1507 Sentence denotes Hematopoeitic cells appear to be the predominant source of inflammasome-induced pro-inflammatory IL-1β in CF.
T17 1508-1661 Sentence denotes PBMCs derived from CF subjects display preserved inflammasome activation and IL-1β secretion in response to the major CF pathogen Pseudomonas aeruginosa.
T18 1662-1837 Sentence denotes However, our data do not support the hypothesis that increased IL-1β production in CF subjects is due to an intrinsic increase in NF-κB activity through loss of CFTR function.